Truveta data used in antipsychotic mortality study
Among 17,004 patients, aripiprazole and quetiapine showed lower mortality than others, and risk varied by diabetes medication use.
See the latest news and media coverage for Truveta. We track all announcements, press releases, and industry mentions in real time, all in one place.
De-identified health data and analytics platform
truveta.comLast updated
In short: Truveta launched Truveta Intelligence, an AI tool for real-time healthcare research, and appointed Erik Wexler to its Board of Directors.
Among 17,004 patients, aripiprazole and quetiapine showed lower mortality than others, and risk varied by diabetes medication use.
ED visit rate increased 7.5-fold from 2023 to 2026, with head/neck injuries common and traumatic brain injuries in 7% of pediatric cases.
Most patients with newly identified HFrEF did not receive recommended repeat echocardiography within one year, despite guidelines.
It enables teams to get answers from real-world data in minutes. Users inspect data, cohorts, and methodology. It unifies workflows into a single system.
Truveta and Knit Health today announced a collaboration to accelerate a new generation of healthcare AI. Their work combines Truveta's large-scale, regulatory-grade real-world data with...
Bellevue, Wash.-based health data company Truveta announced Truveta Intelligence, a new AI-powered tool that lets researchers ask natural language questions and get answers drawn from...
BELLEVUE, Wash., March 31, 2026 (GLOBE NEWSWIRE) -- Grounded in its mission of Saving Lives with Data, Truveta today announced the appointment of Erik Wexler...
BELLEVUE, Wash., March 05, 2026 (GLOBE NEWSWIRE) -- Truveta today announced its participation as a contributing author to a new peer-reviewed Policy Forum article in...
Track Truveta and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Truveta and other trending companies.